<DOC>
	<DOCNO>NCT02933346</DOCNO>
	<brief_summary>Our study seek examine nivolumab efficacy safety advance NSCLC patient treat Temporary Authorization Use ( ATU , compassionate use ) set describe long-term clinical characteristic , notably treatment receive nivolumab discontinuation . The profile patient show great conformity non-selected population , yet clinical data collection reflect `` real life '' condition stop treatment end , enable u get overview post-immunotherapy treatment .</brief_summary>
	<brief_title>Cohort Patients With NSCLC Treated With Nivolumab Under ATU Program</brief_title>
	<detailed_description>Although oncogene addiction concept lead effective target treatment certain histological non-small cell lung cancer ( NSCLC ) type , patient advance tumor still treat first-line chemotherapy . In 2015 , several study demonstrate efficacy nivolumab , immunotherapy target immune checkpoint . In France , besides clinical trial , molecule make available January 2015 Temporary Authorization Use ( ATU , compassionate use ) . Our study seek examine nivolumab efficacy safety advance NSCLC patient treat ATU set describe long-term clinical characteristic , notably treatment receive nivolumab discontinuation . The profile patient show great conformity non-selected population , yet clinical data collection reflect `` real life '' condition stop treatment end , enable u get overview post-immunotherapy treatment .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Long Term Adverse Effects</mesh_term>
	<mesh_term>Nivolumab</mesh_term>
	<criteria>All patient advance NSCLC , noneligible thoracic radiation therapy , receive nivolumab ( least one injection ) , nominative cohort ATU , 23JAN2015 31AUG2015 ( end ATU ) . patient include biomedical research trial nivolumab patient &lt; 18 year old patient include ATU receive nivolumab administration , never patient psychiatric history hinders comprehension information leaflet patient refuse data collect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>